These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 25936305

  • 1. Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.
    Artemeva NV, Safarova MS, Ezhov MV, Afanasieva OI, Dmitrieva OA, Pokrovsky SN.
    Atheroscler Suppl; 2015 May; 18():53-8. PubMed ID: 25936305
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
    Afanasieva OI, Ezhov MV, Razova OA, Afanasieva MI, Utkina EA, Pokrovsky SN.
    Atherosclerosis; 2018 Oct; 277():477-482. PubMed ID: 30270088
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ, Efstathiadou Z, Tselepis AD, Bairaktari ET, Tsironis LD, Tsatsoulis A, Elisaf MS.
    Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
    Kollerits B, Drechsler C, Krane V, Lamina C, März W, Dieplinger H, Ritz E, Wanner C, Kronenberg F, German Diabetes and Dialysis Study Investigators.
    Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
    [Abstract] [Full Text] [Related]

  • 8. [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels].
    Safarova MS, Trukhacheva EP, Ezhov MV, Afanas'eva OI, Afanas'eva MI, Tripoten' MI, Liakishev AA, Pokrovskiĭ SN.
    Kardiologiia; 2011 Nov; 51(5):9-16. PubMed ID: 21649590
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein(a) and coronary heart disease.
    Rodriguez CR, Seman LJ, Ordovas JM, Jenner J, Genest MS, Wilson PW, Schaefer EJ.
    Chem Phys Lipids; 1994 Jan; 67-68():389-98. PubMed ID: 8187239
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, Thiery J, Koch M, von Eckardstein A, Dieplinger H.
    Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
    [Abstract] [Full Text] [Related]

  • 11. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV, Safarova MS, Afanasieva OI, Pogorelova OA, Tripoten MI, Adamova IY, Konovalov GA, Balakhonova TV, Pokrovsky SN.
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
    Kronenberg F, Lhotta K, König P, Margreiter R, Dieplinger H, Utermann G.
    Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a).
    Vavlukis M, Mladenovska K, Daka A, Dimovski A, Domazetovska S, Kuzmanovska S, Kedev S.
    Ann Pharmacother; 2016 Aug; 50(8):609-15. PubMed ID: 27242350
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype.
    Yahya R, Berk K, Verhoeven A, Bos S, van der Zee L, Touw J, Erhart G, Kronenberg F, Timman R, Sijbrands E, Roeters van Lennep J, Mulder M.
    Atherosclerosis; 2019 Oct; 289():201-205. PubMed ID: 31327478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.